Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 2 I, 2000, Pages 523-527

  Henig, Noreen R ^a   Aitken, Moira L ^c   Liu, Mark C ^c   Yu, Albert S ^c   Henderson Jr , William R ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; FOROPAFANT; RECOMBINANT THROMBOCYTE ACTIVATING FACTOR ACETYLHYDROLASE; THROMBOCYTE ACTIVATING FACTOR; TRYPTASE; UNCLASSIFIED DRUG;

ALLERGENICITY; AREA UNDER THE CURVE; ARTICLE; ASTHMA; ATOPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ENZYME ANALYSIS; FORCED EXPIRATORY VOLUME; GASTROENTERITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MYALGIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033841610     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.2.9911084     Document Type: Article

References (21)

1. Eicosanoids and platelet-activating factor in allergic respiratory diseases
2. Increased levels of mblood platelet-activating factor in bronchial asthmatic patients with active symptoms
3. The release of platelet-activating factor into plasma during allergen-induced bronchoconstriction
4. Expression of platelet-activating factor receptor mRNA in human and guinea pig lung
5. Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation
6. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase
7. Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma
8. Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model
9. Standardization of spirometry - 1987 Update
10. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine
11. Analysis of cellular and biochemical constitutents of induced sputum after allergen challenge: A method for studying allergic airway inflammation
12. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma
13. Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma
14. Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses
15. Effect of a platelet-activating factor antagonist, WEB 2086, on allergen induced asthmatic responses
16. Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma
17. Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen
18. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma
19. Allergen challenge increases cell traffic between bone marrow and lung
20. Gas exchange response to a PAF receptor antagonist, SR 27417A, in acute asthma: A pilot study
21. Bronchoscopic evaluation of severe asthma: Persistent inflammation associated with high dose glucocorticoids